Received Feb 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | RA |
loss of appetite; soreness in arm; tiredness; muscle soreness; feeling generally unwell; This is a spontaneous report received from a Consumer or other non HCP. A 75-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 01Feb2025 at 15:15 as dose 1, 0.3 ml single (Batch/Lot number: unknown) at the age of 75 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "high blood pressure" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE; ATORVASTATIN. The following information was reported: MALAISE (non-serious) with onset 02Feb2025 at 09:00, outcome "not recovered", described as "feeling generally unwell"; DECREASED APPETITE (non-serious) with onset 02Feb2025 at 09:00, outcome "not recovered", described as "loss of appetite"; MYALGIA (non-serious) with onset 02Feb2025 at 09:00, outcome "not recovered", described as "muscle soreness"; PAIN IN EXTREMITY (non-serious) with onset 02Feb2025 at 09:00, outcome "not recovered", described as "soreness in arm"; FATIGUE (non-serious) with onset 02Feb2025 at 09:00, outcome "not recovered", described as "tiredness". Therapeutic measures were not taken as a result of decreased appetite, pain in extremity, fatigue, myalgia, malaise. Additional information: The patient did not receive any vaccines on the same date nor within 4 weeks prior to Comirnaty. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Blood pressure high; High cholesterol
HYDROCHLOROTHIAZIDE; ATORVASTATIN